CD19, MS4A1 (CD20), and CD22 are specific target antigens for diseases, such as relapsed/refractory large B-cell lymphoma, mantle cell lymphoma, and diffuse large B-cell lymphoma (DLBCL). Here, CD22 is linked to diffuse large B-cell lymphoma.